These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4619689)

  • 21. The influence of donor factors on development of hypertension following cadaveric renal transplantation in nonhypertensive recipients.
    Fleishhacker JF; Distant DA; Sumrani NB; Hong JH; Sommer BG
    Transplant Proc; 1996 Feb; 28(1):418-9. PubMed ID: 8644299
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical effects of warm ischemia and prolonged preservation on the outcome of transplanted kidneys.
    Toledo-Pereyra LH; Callender CO; Moberg AW; Simmons RL; Najarian JS
    Minn Med; 1976 Jan; 59(1):18-23. PubMed ID: 1107793
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of methods of preservation of cadaver kidneys.
    Sterling WA; Pierce JC; Lee HM; Hume M; Lee BB; Brichta LF; Currier CB; Hasegawa A
    Transplant Proc; 1972 Dec; 4(4):621-3. PubMed ID: 4566808
    [No Abstract]   [Full Text] [Related]  

  • 24. Decreased incidence of acute tubular necrosis after cadaveric donor transplantation due to lidocaine donor pretreatment and low-dose dopamine infusion in the recipient.
    Walaszewski J; Rowinski W; Chmura A; Cajzner S; Kowalczyk J; Danielewicz R; Michalak G; Nawrocki G; Lazowski T; Zawadzki A
    Transplant Proc; 1988 Oct; 20(5):913. PubMed ID: 3055532
    [No Abstract]   [Full Text] [Related]  

  • 25. Analysis of acute rejection episodes during acute tubular necrosis.
    Furukawa T; Hattori R; Kinukawa T; Ohshima S; Fujita T; Ono Y
    Transplant Proc; 1994 Aug; 26(4):1999-2000. PubMed ID: 8066649
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effect of the duration of ischemia on the functioning of the transplanted cadaveric kidney].
    Hofmann K; Hall CL; Grabensee B; Barnes AD
    Med Welt; 1976 Feb; 27(8):391-2. PubMed ID: 768708
    [No Abstract]   [Full Text] [Related]  

  • 27. [Relationship between donor renal graft quality and graft rejection].
    Yu LX; Zeng JH; Fu SJ; Miao Y; Ye GR; DU ZP; Han CX
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):700-2. PubMed ID: 15958313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The impact of rejection episodes during acute tubular necrosis--diagnosis and allograft outcome after cadaveric renal transplants].
    Hoshinaga K; Shiroki R; Kubota Y; Maruyama T; Higuchi T; Tsukiashi Y; Izumitani M; Horiba M; Naide Y
    Hinyokika Kiyo; 1998 May; 44(5):341-6. PubMed ID: 9656107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of irreversible ischemic damage in renal preservation by pharmacological manipulation.
    Mozes MF; Toledo-Pereyra LH; Campos RA; Moberg AW; Najarian JS
    Proc Clin Dial Transplant Forum; 1974; (4):189-92. PubMed ID: 4619662
    [No Abstract]   [Full Text] [Related]  

  • 30. Prognostic factors affecting graft and patient survival in cadaveric and living kidney transplantation.
    Kim SJ; Lee HH; Lee DS; Lee KW; Joh JW; Woo DH; Kwon GY; Oh HY; Kim YG; Huh WS; Kim DJ; Kim GS; Lee SK; Lee BB
    Transplant Proc; 2004 Sep; 36(7):2038-9. PubMed ID: 15518737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for the outcome of cadaveric renal transplantation with non-heart-beating donors.
    Hiraga S; Kitamura M; Abe T; Takebayashi Y; Kakuta T; Ogawa N; Kitajima N; Hida M; Satoh T
    Transplant Proc; 1996 Feb; 28(1):209-11. PubMed ID: 8644181
    [No Abstract]   [Full Text] [Related]  

  • 32. Pretreatment of cadaver donors with cyclophosphamide and methylprednisolone: effect on renal transplant outcome.
    Corry RJ; Patel NP; West JC; Schanbacher BA
    Transplant Proc; 1980 Jun; 12(2):348-51. PubMed ID: 6994305
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of University of Wisconsin solution and University of Rochester (modified Collins) solution for renal preservation in renal transplantation.
    Lai MK; Huang CC; Chu SH; Chuang CK; Chen HW; Chen CS
    Transplant Proc; 1994 Aug; 26(4):2377-8. PubMed ID: 8066779
    [No Abstract]   [Full Text] [Related]  

  • 34. Delayed use of OKT3 for severe acute tubular necrosis in renal transplantation.
    VanderWerf BA
    Transplant Proc; 1996 Aug; 28(4):2115-6. PubMed ID: 8769172
    [No Abstract]   [Full Text] [Related]  

  • 35. Current advantage of FK 506 in cadaveric kidney transplantation.
    Ciancio G; Rosen A; Loreto-Grand B; Burke G; Siquijor A; Luque C; Esquenazi V; Miller J
    Transplant Proc; 1996 Apr; 28(2):1000-1. PubMed ID: 8623207
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of donor age on outcome of kidney transplantation. A two-year analysis of transplants reported to the United Network for Organ Sharing Registry.
    Alexander JW; Bennett LE; Breen TJ
    Transplantation; 1994 Mar; 57(6):871-6. PubMed ID: 8154034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological donor pretreatment in combination with pulsatile preservation in cadaveric renal transplantation.
    Zincke H; Woods JE; Khan AU; Holley KE; Leary FJ
    Transplantation; 1978 Oct; 26(4):207-11. PubMed ID: 360522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procurement and preservation of cadaver kidneys.
    Barry JM
    Urol Clin North Am; 1983 May; 10(2):205-16. PubMed ID: 6344384
    [No Abstract]   [Full Text] [Related]  

  • 39. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A
    Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The results of kidney transplantation].
    Prog Urol; 1996 Oct; 6(5):801-11. PubMed ID: 9102118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.